Latest Breaking News On - Late breaking abstract session - Page 1 : comparemela.com

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMichelle greenmanRacheln grishamSusanna banerjeeDan patersonCharlottec sunPatient impactCompany annual report on formGrade serous ovarian cancer researchExchange commissionRaf and mek programChugai pharmaceutical co ltdSecura bio incGenfleet therapeutics shanghai incSociety of gynecologic oncology

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs -March 11, 2024 at 07:31 am EDT

Late-breaking oral presentation of a subgroup analysis in RAMP 201 Part A heavily pretreated patients receiving avutometinib and defactinib and their best response compared to most recent prior.

San diegoUnited statesMichelle greenmanRacheln grishamDan patersonCharlottec sunSusanna banerjeeExchange commissionDrug administrationPatient impactGenfleet therapeutics shanghai incRaf and mek programChugai pharmaceutical co ltdSociety of gynecologic oncologySecura bio incCompany annual report on form

TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

TriSalus Life Sciences® Inc., , an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced.

United statesSan diegoChandrac ghoshSapanp patelMichaels leeUniversity of texas md anderson cancer centerTrisalus life sciencesUveal melanoma programSociety for immunotherapy of cancerExchange commissionTrisalus lifeAnnual meetingBreaker oral presentationClinical activityImmune checkpoint inhibitionMetastatic uveal melanoma liver metastasis

ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Results from MIRASOL Also Show ELAHERE is the First Treatment to Demonstrate an Overall Survival Benefit in a Phase 3 Trial in Platinum-Resistant Ovarian Cancer Compared to Chemotherapy Clinically. | June 4, 2023

United statesUniversity of oklahomaDavid omalleyKathleen moorePivekimab sunirineMirvetuximab soravtansineSarah cannon phasei programJames cancer centerUniversity of texas md anderson cancer centerAmerican society of clinical oncologyImmunogen incClinical researchOhio state universityDepartment of leukemiaClinical oncologyAnnual meeting

Immunogen (IMGN) Announces Presentation of Results from the Phase 3 MIRASOL Trial

Immunogen (IMGN) Announces Presentation of Results from the Phase 3 MIRASOL Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of oklahomaAnabel chanDavid omalleyRobert stanislaroMirvetuximab soravtansinePivekimab sunirineKathleen mooreAnna berkenblitCourtney okonekUniversity of texas md anderson cancer centerCompany annual report on formExchange commission onSarah cannon phasei programExchange commision onCompany quarterly report on form